119 related articles for article (PubMed ID: 3296436)
1. [Antitumor immunity].
Gordienko SP
Vopr Onkol; 1987; 33(4):87-91. PubMed ID: 3296436
[No Abstract] [Full Text] [Related]
2. [Immunity and immunosuppression in tumor growth].
Govallo VI
Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
[No Abstract] [Full Text] [Related]
3. [On the criticism of antitumor immunity: arguments for and against].
Revskoĭ SIu; Dil'man VM
Vopr Onkol; 1988; 34(4):477-81. PubMed ID: 3287765
[No Abstract] [Full Text] [Related]
4. Cancer immunology--an overview.
Richards V
Prog Exp Tumor Res; 1980; 25():1-60. PubMed ID: 6986628
[No Abstract] [Full Text] [Related]
5. [Radiotherapy and antitumor immunity. Immunomodifying action of ionizing radiation].
Klimovich VB
Med Radiol (Mosk); 1983 Jul; 28(7):77-84. PubMed ID: 6224065
[No Abstract] [Full Text] [Related]
6. [A new hypothesis on the immune surveillance of tumors].
Jansa P
Acta Univ Palacki Olomuc Fac Med; 1984; 107():139-42. PubMed ID: 6242634
[No Abstract] [Full Text] [Related]
7. [Regulation of immunological response by macrophages].
Ptak W; Marcinkiewicz J
Postepy Hig Med Dosw; 1981; 35(1):1-35. PubMed ID: 7038646
[No Abstract] [Full Text] [Related]
8. The gordian knot of tumour immunology.
Amlot P
Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
[No Abstract] [Full Text] [Related]
9. [Cytotoxic cells of the NK type - their characteristics and role in anti-neoplastic immunity].
Janiak M; Lipski S
Postepy Hig Med Dosw; 1982; 36(1-3):95-131. PubMed ID: 6763997
[No Abstract] [Full Text] [Related]
10. [Immunoreactivity in tumor growth].
Fel' VIa
Vopr Onkol; 1987; 33(4):99-106. PubMed ID: 3296438
[No Abstract] [Full Text] [Related]
11. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
[No Abstract] [Full Text] [Related]
12. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
13. Cancer in immunosuppressed experimental animals and human patients.
Allison AC
Johns Hopkins Med J Suppl; 1974; 3():341-51. PubMed ID: 4370940
[No Abstract] [Full Text] [Related]
14. On immunosurveillance in human cancer.
Thomas L
Yale J Biol Med; 1982; 55(3-4):329-33. PubMed ID: 6758376
[TBL] [Abstract][Full Text] [Related]
15. [Immunological properties of tumor cells that determine the degree of their malignancy].
Lavrovskiĭ VA; Viksler VKh
Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110
[No Abstract] [Full Text] [Related]
16. [Immunosuppression mechanism affecting the development of neoplasms].
Rupniewska ZM; Kurowska M
Pol Tyg Lek; 1980 Mar; 35(12):455-7. PubMed ID: 6966796
[No Abstract] [Full Text] [Related]
17. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
18. [Tumor genesis as an immunologic problem].
Rapp W
Med Welt; 1972 May; 23(21):788-92. PubMed ID: 5040396
[No Abstract] [Full Text] [Related]
19. Promises and limitations of murine models in the development of anticancer T-cell vaccines.
Lévy F; Colombetti S
Int Rev Immunol; 2006; 25(5-6):269-95. PubMed ID: 17169777
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].
Marconi P; Bistoni F
Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
